(NIH/National Institute of Allergy and Infectious Diseases) A trial of an experimental drug designed to treat cravings associated with opioid use disorder (OUD) has begun at the National Institutes of Health. The trial will assess the safety and pharmacokinetics of ANS-6637 when given with another drug that is processed by the same liver enzyme pathway. Trial funding is through NIH's Helping to End Addiction Long-Term (HEAL) Initiative, a program to accelerate research efforts to stem the public health crisis of OUD.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2TsUHZS
No comments:
Post a Comment